Reduced lung function predicts increased fatality in future cardiac events. A population-based study

Journal of Internal Medicine

Volumn 260, Issue 6, 2006, Pages 560-567

  Engstrom G ^a   Hedblad, B ^a   Janzon, L ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; Epidemiology; Forced expiratory volume; Forced vital capacity

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; COURSE EVALUATION; EXPIRATORY RESERVE VOLUME; FATALITY; FOLLOW UP; FORCED EXPIRATORY VOLUME; HAZARD ASSESSMENT; HUMAN; INCIDENCE; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SAMPLE SIZE; SCREENING TEST; SWEDEN;

ADULT; CORONARY DISEASE; FORCED EXPIRATORY VOLUME; HEART DISEASES; HUMANS; INCIDENCE; LUNG; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POPULATION SURVEILLANCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SWEDEN; VITAL CAPACITY;

EID: 33751099568     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01718.x     Document Type: Article

References (32)

1. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976; 294: 1071-5.
2. Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L. Occurrence and prognostic significance of ventricular arrhythmias is related to pulmonary function. A study from 'Men born in 1914', Malmö, Sweden. Circulation 2001; 103: 3086-91.
3. Kannel WB, Hubert H, Lew EA. Vital capacity as a predictor of cardiovascular disease. Am Heart J 1983; 105: 311-5.
4. Hole DJ, Watt GCM, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 711-5.
5. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990; 43: 867-73.
6. Engström G, Hedblad B, Valind S, Janzon L. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity. Atherosclerosis 2001; 155: 237-43.
7. Knuiman MW, James AL, Divitini ML, Ryan G, Bartholomew HC, Musk AW. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999; 9: 297-306.
8. Schroeder EB, Welch VL, Couper D et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003; 158: 1171-81.
9. Engström G, Lind P, Hedblad B et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555-60.
10. Chambless L, Keil U, Dobson A et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation 1997; 96: 3849-59.
11. Michalodimitrakis M, Mavroforou A, Giannoukas AD. Lessons learnt from the autopsies of 445 cases of sudden cardiac death in adults. Coron Artery Dis 2005; 16: 385-9.
12. Manolio TA, Furberg CD, Rautaharju PM et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol 1994; 23: 916-25.
13. Engström G, Hedblad B, Stavenow L et al. Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study. Circulation 2004; 110: 27-31.
14. Berglund G, Eriksson KF, Israelsson B et al. Cardiovascular risk groups and mortality in an urban Swedish male population: the Malmö Preventive Project. J Intern Med 1996; 239: 489-97.
15. Engström G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgärde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 2002; 105: 2632-7.
16. Standardised lung function testing. Official statement of the European Respiratory Society. Eur Resp J 1993; 6(Suppl. 16): 1-27.
17. Engström G, Wollmer P, Valind S, Hedblad B, Janzon L. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914'. J Hypertens 2001; 19: 1203-8.
18. Engström G, Janzon L. Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med 2002; 19: 167-70.
19. Laurell CB. Electroimmuno assay. Scand J Clin Lab Invest Suppl 1972; 124: 21-37.
20. Engström G, Berglund G, Göransson M et al. Distribution and determinants of ischaemic heart disease in an urban population. A study from the myocardial infarction register in Malmö, Sweden. J Intern Med 2000; 247: 588-96.
21. Värdering av diagnoskvaliten för akut hjärtinfarkt i patientregistret 1987 och 1995. Stockholm, Sweden: The National Board of Health and Welfare. http://www.socialstyrelsen.se (in Swedish).
22. Gardner SC, Grunwald GK, Rumsfeld JS et al. Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg 2001; 72: 2033-7.
23. Selvaraj CL, Gurm HS, Gupta R, Ellis SG, Bhatt DL. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2005; 96: 756-9.
24. Sparrow D, Weiss ST, Vokonas PS, Cupples LA, Ekerdt DJ, Colton T. Forced vital capacity and the risk of hypertension. The Normative Aging Study. Am J Epidemiol 1988; 127: 734-41.
25. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003; 253: 574-81.
26. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514-9.
27. Dahl M, Tybjaerg-Hansen A, Vestbo J, Lange P, Nordestgaard BG. Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1008-11.
28. Njolstad I, Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study. Arch Intern Med 1998; 158: 1326-32.
29. Wannamethee G, Whincup PH, Shaper AG, Walker M, MacFarlane PW. Factors determining case fatality in myocardial infarction 'who dies in a heart attack'? Br Heart J 1995; 74: 324-31.
30. Kannel WB, Sorlie P, Castelli WP, McGee D. Blood pressure and survival after myocardial infarction: the Framingham study. Am J Cardiol 1980; 45: 326-30.
31. Chun BY, Dobson AJ, Heller RF. The impact of diabetes on survival among patients with first myocardial infarction. Diabetes Care 1997; 20: 704-8.
32. de Bruyne MC, Mosterd A, Hoes AW et al. Prevalence, determinants, and misclassification of myocardial infarction in the elderly. Epidemiology 1997; 8: 495-500.